|
PharmaMar to present data on anticancer candidates PM1183 and plitidepsin at the AACR
American Association for Cancer Research Annual Meeting April 18-22, 2015 Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic effect...
More... |
| All times are GMT -7. The time now is 01:14 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021